Welcome to Journal of Clinical Pathway’s new case report exploration. This interactive case report will engage your experience and knowledge about the details of a given case. Along the way, we will provide details and at the end, we will share the patient’s outcome. READ MORE


Aldoxorubicin improves progression-free survival in patients with metastatic or locally advanced unresectable soft-tissue sarcoma.